Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Metabolic Response
100%
18F-fluorodeoxyglucose (18F-FDG)
100%
SUVmax
100%
Locally Advanced Breast Cancer
100%
Response to Neoadjuvant Chemotherapy
100%
Miller-Payne
60%
Worse Prognosis
40%
Non-responders
40%
Neoadjuvant Chemotherapy
40%
Good Prognosis
40%
RECIST Criteria
40%
Tumor Cellularity
40%
Histological Analysis
20%
Treatment Completion
20%
Partial Responder
20%
Before Surgery
20%
Epirubicin
20%
Tumor Size
20%
Post-chemotherapy
20%
Cyclophosphamide
20%
Taxanes
20%
FDG PET-CT
20%
FDG Uptake
20%
Overall Accuracy
20%
4-cycle
20%
CT Scanner
20%
Weighted kappa
20%
CT Quantification
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Breast Cancer
100%
Fluorodeoxyglucose F 18
100%
Polyethylene Terephthalate
100%
Neoplasm
50%
Cyclophosphamide
16%
Epirubicin
16%
Taxane
16%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Fluorodeoxyglucose F 18
100%
Neoadjuvant Chemotherapy
100%
Locally Advanced Breast Cancer
100%
Neoplasm
50%
Epirubicin
16%
Cyclophosphamide
16%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Positron Emission Tomography-Computed Tomography
100%
Tumor Volume
16%
Epirubicin
16%
Cyclophosphamide
16%